Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the Karolinska series

Urology

Volumn 50, Issue 5, 1997, Pages 722-726

  Adolfsson, Jan ^a   Steineck, Gunnar ^b   Hedlund, Per Olov ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SWEDEN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0030724269     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00320-8     Document Type: Article

References (23)

1. Adolfsson J, Carstensen J, and Löwhagen T: Deferred treatment in clinically localized prostatic carcinoma. Br J Urol 69: 183-187, 1992.
2. Johansson JE: Expectant management of early stage prostate cancer: Swedish experience. J Urol 152(5 Pt 2): 1753-1756, 1994.
3. Adolfsson J, Steineck G, and Whitmore WF Jr: Recent results of management of palpable clinically localized prostate cancer. Cancer 72: 310-322, 1993.
4. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG Jr, Wennberg JE, and the Prostate Disease Outcome Research Team: A structured literature review of treatment for localized prostate cancer. Arch Fam Med 2: 487-493, 1993.
5. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnik MI, Smalley SR, et al: Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. J Urol 154: 2144-2148, 1995.
6. Whitmore WF Jr: Localised prostatic cancer: management and detection issues. Lancet 343: 1263-1267, 1994.
7. Esposti PL: Cytologic malignancy grading of prostate carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 5: 199-209, 1971.
8. Hermanek P, and Sobin LH (Eds): UICC (Union International Contre le Cancer). TNM Classification of Malignant Tumors. New York, Springer Verlag, 1978.
9. Hermanek P, and Sobin LH (Eds): UICC (Union International Contre le Cancer). TNM Classification of Malignant tumors. New York, Springer Verlag, 1992.
10. Berkson J, and Gage R: Calculation of survival rates for cancer. Mayo Clin Proc 25: 270-274, 1950.
11. Clayton D, and Hills M: Statistical Models in Epidemiology. New York, Oxford University Press, 1993.
12. Chodak GW, Thiested RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskowitz B, Livine PM, and Warner J: Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248, 1994.
13. Johansson JE, Holmberg L, Johansson S, Bergström R, and Adami HO: Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 277: 467-471, 1997.
14. Aus G, Hugosson J, and Norlén L: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 154: 460-465, 1995.
15. Abrahamsson PA, Adami HO, Taube A, Kim K, Zelen M, and Kulldorf M: Re: long-term survival and mortality in prostate cancer treated with noncurative intent (letter). J Urol 155: 296-298, 1996.
16. Warner J, and Whitmore WF Jr: Expectant management of clinically localized prostatic cancer. J Urol 152(5 Pt 2): 1761-1765, 1994.
17. Schellhammer PF: Contemporary expectant therapy series: a viewpoint. Urology 44(6A): 47-52, 1994.
18. Waisman J, Adolfsson J, Löwhagen T, and Skoog L: Comparison of transrectal prostate digital aspiration and ultrasound-guided core biopsies in 99 men. Urology 37: 301-307, 1991.
19. Chodak GW, Bibbi M, Straus FH 2nd, Wied GL, and Straus FH: Transrectal aspiration biopsy versus transperineal core biopsy for the diagnosis of carcinoma of the prostate. J Urol 132: 480-482, 1984.
20. Narayan P, Jajodia P, Stein R, and Tanagho EA: A comparison of fine needle aspiration and core biopsy in diagnosis and preoperative grading of prostate cancer. J Urol 141: 560-563, 1989.
21. Pearson JD, and Carter HB: Natural history of changes in prostate specific antigen in early stage prostate cancer. J Urol 152(5 Pt 2): 1743-1748, 1994.
22. Stenman UH, Hakama M, Knekt P, Teppo L, and Leinonen J: Serum concentrations of prostate specific antigen and its complex with alfa 1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344: 1594-1598, 1994.
23. Tibblin G, Welin L, Bergström R, Ronquist G, Norlén BJ, and Adami HO: The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913. J Urol 154: 1386-1389, 1995.